UCB is sponsoring an effort to create a clinical care standard for women with inflammatory bowel disease (IBD) before, during and after pregnancy.
The FDA has OK’d the Daewoong manufacturing plant that will make Evolus’ Botox copy but rejected Evolus' drug over its manufacturing design.
Samsung BioLogics is well on its way to becoming the world's largest contract manufacturer.
The One Show’s return to health and pharma recently resulted in a slew of creative awards, but only one of them went to an actual drugmaker.
An ad within an ad is the theme of AstraZeneca’s first DTC campaign for Fasenra.
The copay coupon fight is getting hotter than ever.
AbbVie tried to replace its Imbruvica formula with a single-pill version that cost three times as much for some patients. That didn't go over well.
Artificial intelligence companies are coming up with all kinds of ways to help pharma. So how can pharma return the favor?
President Trump's push to force price tags into drug advertising has pharma marketers worried and full of questions.
Newly unsealed court documents allege Insys provided incentives for off-label prescribing of its painkiller Subsys.
Doctors who got free meals, speaking fees and other payments from drugmakers also prescribed more opioids, a new analysis found.